Physician profile
Robert J Taylor
NPI 1528473543
$3,585.52
in general payments reported to CMS, 2019-2025
13 companies · $2,674 in 2025
The $2,674 reported for 2025 was more than what 93% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $278 · 2022: $147 · 2023: $18.65 · 2024: $469 · 2025: $2,674.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,219 · Food and Beverage: $942.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,219.18 |
| Food and Beverage | $941.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $1,467.34 | 2025 | |
| Integra Lifesciences Corporation | $1,448.76 | 2024-2025 | Integra, Inspira Air, Acclarent Aera |
| Genzyme Corporation | $277.05 | 2021-2023 | |
| Smith+Nephew, INC. | $125.27 | 2022 | |
| Medtronic, INC. | $61.06 | 2025 | Straightshot, Stealthstation S8 Platform |
| Grifols USA, LLC | $54.03 | 2025 | Prolastin-C Liquid |
| Stryker Corporation | $27.71 | 2024 | Audion Et Dilation System |
| Abbott Laboratories | $25.52 | 2025 | Freestyle Libre 3 |
| Millicent US INC | $23.28 | 2025 | Femlyv |
| Pharmacyclics LLC, An Abbvie Company | $21.59 | 2022 | |
| Alk-Abello, INC | $19.36 | 2021 | |
| Alnylam Pharmaceuticals INC. | $18.87 | 2025 | Onpattro |
| Pfizer INC. | $15.68 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.